Bhubaneswar, Jan. 28 -- India's pharmaceutical and medical devices industry is set for a major global leap following the successful conclusion of the India-European Union Free Trade Agreement (FTA). The landmark pact marks a decisive step in deepening economic ties between two of the world's largest economies, while significantly strengthening India's footprint in global healthcare supply chains.

With the agreement in place, Indian manufacturers gain enhanced access to the European Union's pharmaceuticals and medical devices market, currently valued at $572.3 billion. The move is expected to unlock fresh export opportunities, scale up production capacities and reinforce India's growing reputation as a dependable supplier of affordable, h...